Kensington Investment Counsel’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Sell |
1,697
-15
| -0.9% | -$3.28K | 0.16% | 82 |
|
|
2025
Q1 | $383K | Sell |
1,712
-47
| -3% | -$10.5K | 0.17% | 82 |
|
|
2024
Q4 | $576K | Buy |
1,759
+7
| +0.4% | +$2.29K | 0.24% | 81 |
|
|
2024
Q3 | $526K | Buy |
1,752
+47
| +3% | +$14.1K | 0.22% | 85 |
|
|
2024
Q2 | $562K | Sell |
1,705
-24
| -1% | -$7.91K | 0.25% | 83 |
|
|
2024
Q1 | $684K | Buy |
1,729
+149
| +9% | +$59K | 0.31% | 81 |
|
|
2023
Q4 | $556K | Buy |
1,580
+17
| +1% | +$5.99K | 0.29% | 80 |
|
|
2023
Q3 | $586K | Buy |
1,563
+124
| +9% | +$46.5K | 0.36% | 74 |
|
|
2023
Q2 | $550K | Sell |
1,439
-21
| -1% | -$8.03K | 0.35% | 79 |
|
|
2023
Q1 | $506K | Sell |
1,460
-135
| -8% | -$46.8K | 0.38% | 74 |
|
|
2022
Q4 | $375K | Sell |
1,595
-83
| -5% | -$19.5K | 0.29% | 75 |
|
|
2022
Q3 | $413K | Buy |
1,678
+8
| +0.5% | +$1.97K | 0.35% | 75 |
|
|
2022
Q2 | $505K | Sell |
1,670
-5
| -0.3% | -$1.51K | 0.43% | 73 |
|
|
2022
Q1 | $688K | Sell |
1,675
-2,286
| -58% | -$939K | 0.46% | 78 |
|
|
2021
Q4 | $1.86M | Buy |
+3,961
| New | +$1.86M | 1.08% | 40 |
|
|
2021
Q2 | $1.28M | Buy |
3,568
+65
| +2% | +$23.3K | 0.88% | 55 |
|
|
2021
Q1 | $987K | Buy |
3,503
+134
| +4% | +$37.8K | 0.74% | 69 |
|
|
2020
Q4 | $954K | Buy |
+3,369
| New | +$954K | 0.79% | 66 |
|